ID | 109597 |
著者 |
ヒロセ, カヨ
Department of Pharmacology, Institute of Health Biosciences, the University of Tokushima Graduate School|Department of Anesthesiology, Tokyo University Graduate School of Medicine
高石, 和美
Department of Dental Anesthesiology, Institute of Health Biosciences, the University of Tokushima Graduate School
徳島大学 教育研究者総覧
KAKEN研究者をさがす
カワハラ, トミヤ
Department of Anesthesiology, Tokushima University Hospital
カタヤマ, トシコ
Department of Anesthesiology, Tokushima University Hospital
森根, 裕二
Department of Digestive and Pediatric Surgery, Tokushima University Hospital
徳島大学 教育研究者総覧
KAKEN研究者をさがす
池本, 哲也
Department of Digestive and Pediatric Surgery, Tokushima University Hospital
徳島大学 教育研究者総覧
KAKEN研究者をさがす
島田, 光生
Department of Digestive and Pediatric Surgery, Tokushima University Hospital
徳島大学 教育研究者総覧
KAKEN研究者をさがす
松久, 宗英
Diabetes Therapeutics and Research Center, the University of Tokushima
徳島大学 教育研究者総覧
KAKEN研究者をさがす
北畑, 洋
Department of Dental Anesthesiology, Institute of Health Biosciences, the University of Tokushima Graduate School
徳島大学 教育研究者総覧
KAKEN研究者をさがす
|
キーワード | insulinoma
perioperative glucose management
artificial endocrine pancreas
anesthetic management
continuous blood glucose monitoring
|
資料タイプ |
学術雑誌論文
|
抄録 | A 71-year-old woman had an episode of syncope due to hypoglycemia of 27 mg/dl. She was diagnosed with insulinoma and scheduled for laparoscopic enucleation along with the use of an artificial endocrine pancreas (STG-22, Nikkiso Co., Ltd., Tokyo, Japan). Anesthesia was maintained with sevoflurane and remifentanil. Her blood glucose level was controlled using the artificial endocrine pancreas, which enabled continuous blood glucose monitoring and computer-operated glucose and insulin infusion to maintain the blood glucose level at a steady state. The target concentration of blood glucose was set at 80-120 mg/dl during surgery. Until removal of the tumor, the blood glucose level was kept at around 80-100 mg/dl. After removal of the tumor, the blood glucose level gradually increased, but it was kept in the normal range by the artificial endocrine pancreas. The artificial endocrine pancreas was useful to monitor and maintain blood glucose levels during and after the removal of insulinoma, without any hyper- or hypoglycemia.
|
掲載誌名 |
The journal of medical investigation : JMI
|
ISSN | 13431420
|
cat書誌ID | AA11166929
|
巻 | 61
|
号 | 3-4
|
開始ページ | 421
|
終了ページ | 425
|
並び順 | 421
|
発行日 | 2014-08
|
EDB ID | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
医学系
病院
先端酵素学研究所
歯学系
|